 Global Finasteride (Oral Route) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Finasteride (Oral Route) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032. Fina... もっと見る
SummaryThe global Finasteride (Oral Route) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.Finasteride, when taken orally, is a medication used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also prescribed to treat male pattern hair loss (androgenetic alopecia) in men. Finasteride works by inhibiting the action of the enzyme 5-alpha reductase, which converts the male hormone testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, finasteride helps to shrink the prostate and promote hair regrowth in men with male pattern baldness. It is important to note that finasteride should only be taken as prescribed by a healthcare provider, as it can have side effects and may not be suitable for everyone. In 2025, the North America Finasteride (Oral Route) market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period. Major global manufacturers of Finasteride (Oral Route) include Merck, Sandoz, Actavis, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Hangzhou Kangenbei Pharmaceutical Co., Ltd, Hunan Zhengqing Pharmaceutical Group Co., Ltd, Tianfang Pharmaceutical Co., Ltd, among others. In 2025, the top five players accounted for approximately % of global market revenue. In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %. The global Finasteride (Oral Route) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032. Market Segmentation By Company: Merck Sandoz Actavis Cipla RelonChem Dr. Reddy Accord Pharmaceuticals Hangzhou Kangenbei Pharmaceutical Co., Ltd Hunan Zhengqing Pharmaceutical Group Co., Ltd Tianfang Pharmaceutical Co., Ltd Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Zhejiang Xianju Pharmaceutical Co., Ltd Shanghai Hyundai Pharmaceutical Co., Ltd Hunan Baicao Pharmaceutical Co., Ltd Guangdong Yishu Pharmaceutical Co., Ltd CR SECCO Pharmaceutical Co., Ltd Shanghai Xinya Pharmaceutical Minhang Co., Ltd Renhetang Pharmaceutical Company Limited Runenberg Pharmaceuticals Ltd Nanjing Shenghe Pharmaceutical Co., Ltd Nanjing Sea Whale Pharmaceutical Co., Ltd Segment by Type 1mg 5mg Segment by Application Urology Dermatology Macro-Region - North America - Europe - Asia-Pacific - South America - Middle East & Africa Micro-Local Market North America Europe China Japan Chapter Outline Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term Chapter 2: Quantitative analysis of Finasteride (Oral Route) sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region Chapter 3: Competitive landscape of Finasteride (Oral Route) manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans) Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment) Chapter 7: Key manufacturer profiles –company overview, Finasteride (Oral Route) product descriptions and specifications, revenue, gross margins, and recent developments Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies Chapter 11: Key findings, main takeaways, and overall conclusions of the report. Why This Report? Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Finasteride (Oral Route) value chain, addressing: - Market entry risks/opportunities by region - Product mix optimization based on local practices - Competitor tactics in fragmented vs. consolidated markets Table of Contents1 Market Overview1.1 Finasteride (Oral Route) Product Scope 1.2 Finasteride (Oral Route) by Type 1.2.1 Global Finasteride (Oral Route) Sales by Type (2021, 2025 & 2032) 1.2.2 1mg 1.2.3 5mg 1.3 Finasteride (Oral Route) by Application 1.3.1 Global Finasteride (Oral Route) Sales Comparison by Application (2021, 2025 & 2032) 1.3.2 Urology 1.3.3 Dermatology 1.4 Global Finasteride (Oral Route) Market Estimates and Forecasts (2021-2032) 1.4.1 Global Finasteride (Oral Route) Market Size (Value) and Growth Rate (2021-2032) 1.4.2 Global Finasteride (Oral Route) Market Size (Volume) and Growth Rate (2021-2032) 1.4.3 Global Finasteride (Oral Route) Price Trends (2021-2032) 1.5 Assumptions and Limitations 2 Market Size and Prospects by Region 2.1 Global Finasteride (Oral Route) Market Size by Region: 2021 VS 2025 VS 2032 2.2 Global Finasteride (Oral Route) Historical Market Scenario by Region (2021-2026) 2.2.1 Global Finasteride (Oral Route) Sales Market Share by Region (2021-2026) 2.2.2 Global Finasteride (Oral Route) Revenue Market Share by Region (2021-2026) 2.3 Global Finasteride (Oral Route) Market Estimates and Forecasts by Region (2027-2032) 2.3.1 Global Finasteride (Oral Route) Sales Estimates and Forecasts by Region (2027-2032) 2.3.2 Global Finasteride (Oral Route) Revenue Forecast by Region (2027-2032) 2.4 Major Regions and Emerging Market Analysis 2.4.1 North America Finasteride (Oral Route) Market Size and Prospects (2021-2032) 2.4.2 Europe Finasteride (Oral Route) Market Size and Prospects (2021-2032) 2.4.3 China Finasteride (Oral Route) Market Size and Prospects (2021-2032) 2.4.4 Japan Finasteride (Oral Route) Market Size and Prospects (2021-2032) 3 Global Market Size by Type 3.1 Global Finasteride (Oral Route) Historical Market Review by Type (2021-2026) 3.1.1 Global Finasteride (Oral Route) Sales by Type (2021-2026) 3.1.2 Global Finasteride (Oral Route) Revenue by Type (2021-2026) 3.1.3 Global Finasteride (Oral Route) Average Price by Type (2021-2026) 3.2 Global Finasteride (Oral Route) Market Estimates and Forecasts by Type (2027-2032) 3.2.1 Global Finasteride (Oral Route) Sales Forecast by Type (2027-2032) 3.2.2 Global Finasteride (Oral Route) Revenue Forecast by Type (2027-2032) 3.2.3 Global Finasteride (Oral Route) Price Forecast by Type (2027-2032) 3.3 Representative Players for Different Types of Finasteride (Oral Route) 4 Global Market Size by Application 4.1 Global Finasteride (Oral Route) Historical Market Review by Application (2021-2026) 4.1.1 Global Finasteride (Oral Route) Sales by Application (2021-2026) 4.1.2 Global Finasteride (Oral Route) Revenue by Application (2021-2026) 4.1.3 Global Finasteride (Oral Route) Average Price by Application (2021-2026) 4.2 Global Finasteride (Oral Route) Market Estimates and Forecasts by Application (2027-2032) 4.2.1 Global Finasteride (Oral Route) Sales Forecast by Application (2027-2032) 4.2.2 Global Finasteride (Oral Route) Revenue Forecast by Application (2027-2032) 4.2.3 Global Finasteride (Oral Route) Price Forecast by Application (2027-2032) 4.3 New Sources of Growth in Finasteride (Oral Route) Applications 5 Competition Landscape by Players 5.1 Global Finasteride (Oral Route) Sales by Player (2021-2026) 5.2 Global Top Finasteride (Oral Route) Players by Revenue (2021-2026) 5.3 Global Finasteride (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Finasteride (Oral Route) revenue as of 2025 5.4 Global Finasteride (Oral Route) Average Price by Company (2021-2026) 5.5 Global Key Manufacturers of Finasteride (Oral Route), Manufacturing Sites & Headquarters 5.6 Global Key Manufacturers of Finasteride (Oral Route), Product Type & Application 5.7 Global Key Manufacturers of Finasteride (Oral Route), Date of Entry into This Industry 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans 6 Regional Analysis 6.1 North America Market: Players, Segments, Downstream and Major Customers 6.1.1 North America Finasteride (Oral Route) Sales by Company 6.1.1.1 North America Finasteride (Oral Route) Sales by Company (2021-2026) 6.1.1.2 North America Finasteride (Oral Route) Revenue by Company (2021-2026) 6.1.2 North America Finasteride (Oral Route) Sales Breakdown by Type (2021-2026) 6.1.3 North America Finasteride (Oral Route) Sales Breakdown by Application (2021-2026) 6.1.4 North America Finasteride (Oral Route) Major Customers 6.1.5 North America Market Trends and Opportunities 6.2 Europe Market: Players, Segments, Downstream and Major Customers 6.2.1 Europe Finasteride (Oral Route) Sales by Company 6.2.1.1 Europe Finasteride (Oral Route) Sales by Company (2021-2026) 6.2.1.2 Europe Finasteride (Oral Route) Revenue by Company (2021-2026) 6.2.2 Europe Finasteride (Oral Route) Sales Breakdown by Type (2021-2026) 6.2.3 Europe Finasteride (Oral Route) Sales Breakdown by Application (2021-2026) 6.2.4 Europe Finasteride (Oral Route) Major Customers 6.2.5 Europe Market Trends and Opportunities 6.3 China Market: Players, Segments, Downstream and Major Customers 6.3.1 China Finasteride (Oral Route) Sales by Company 6.3.1.1 China Finasteride (Oral Route) Sales by Company (2021-2026) 6.3.1.2 China Finasteride (Oral Route) Revenue by Company (2021-2026) 6.3.2 China Finasteride (Oral Route) Sales Breakdown by Type (2021-2026) 6.3.3 China Finasteride (Oral Route) Sales Breakdown by Application (2021-2026) 6.3.4 China Finasteride (Oral Route) Major Customers 6.3.5 China Market Trends and Opportunities 6.4 Japan Market: Players, Segments, Downstream and Major Customers 6.4.1 Japan Finasteride (Oral Route) Sales by Company 6.4.1.1 Japan Finasteride (Oral Route) Sales by Company (2021-2026) 6.4.1.2 Japan Finasteride (Oral Route) Revenue by Company (2021-2026) 6.4.2 Japan Finasteride (Oral Route) Sales Breakdown by Type (2021-2026) 6.4.3 Japan Finasteride (Oral Route) Sales Breakdown by Application (2021-2026) 6.4.4 Japan Finasteride (Oral Route) Major Customers 6.4.5 Japan Market Trends and Opportunities 7 Company Profiles and Key Figures 7.1 Merck 7.1.1 Merck Company Information 7.1.2 Merck Business Overview 7.1.3 Merck Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.1.4 Merck Finasteride (Oral Route) Products Offered 7.1.5 Merck Recent Development 7.2 Sandoz 7.2.1 Sandoz Company Information 7.2.2 Sandoz Business Overview 7.2.3 Sandoz Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.2.4 Sandoz Finasteride (Oral Route) Products Offered 7.2.5 Sandoz Recent Development 7.3 Actavis 7.3.1 Actavis Company Information 7.3.2 Actavis Business Overview 7.3.3 Actavis Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.3.4 Actavis Finasteride (Oral Route) Products Offered 7.3.5 Actavis Recent Development 7.4 Cipla 7.4.1 Cipla Company Information 7.4.2 Cipla Business Overview 7.4.3 Cipla Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.4.4 Cipla Finasteride (Oral Route) Products Offered 7.4.5 Cipla Recent Development 7.5 RelonChem 7.5.1 RelonChem Company Information 7.5.2 RelonChem Business Overview 7.5.3 RelonChem Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.5.4 RelonChem Finasteride (Oral Route) Products Offered 7.5.5 RelonChem Recent Development 7.6 Dr. Reddy 7.6.1 Dr. Reddy Company Information 7.6.2 Dr. Reddy Business Overview 7.6.3 Dr. Reddy Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.6.4 Dr. Reddy Finasteride (Oral Route) Products Offered 7.6.5 Dr. Reddy Recent Development 7.7 Accord Pharmaceuticals 7.7.1 Accord Pharmaceuticals Company Information 7.7.2 Accord Pharmaceuticals Business Overview 7.7.3 Accord Pharmaceuticals Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.7.4 Accord Pharmaceuticals Finasteride (Oral Route) Products Offered 7.7.5 Accord Pharmaceuticals Recent Development 7.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd 7.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information 7.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview 7.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Development 7.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd 7.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information 7.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview 7.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Products Offered 7.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Development 7.10 Tianfang Pharmaceutical Co., Ltd 7.10.1 Tianfang Pharmaceutical Co., Ltd Company Information 7.10.2 Tianfang Pharmaceutical Co., Ltd Business Overview 7.10.3 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.10.4 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.10.5 Tianfang Pharmaceutical Co., Ltd Recent Development 7.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd 7.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information 7.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview 7.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Development 7.12 Zhejiang Xianju Pharmaceutical Co., Ltd 7.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information 7.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview 7.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Development 7.13 Shanghai Hyundai Pharmaceutical Co., Ltd 7.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Company Information 7.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview 7.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Development 7.14 Hunan Baicao Pharmaceutical Co., Ltd 7.14.1 Hunan Baicao Pharmaceutical Co., Ltd Company Information 7.14.2 Hunan Baicao Pharmaceutical Co., Ltd Business Overview 7.14.3 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.14.4 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Development 7.15 Guangdong Yishu Pharmaceutical Co., Ltd 7.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Company Information 7.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Business Overview 7.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Development 7.16 CR SECCO Pharmaceutical Co., Ltd 7.16.1 CR SECCO Pharmaceutical Co., Ltd Company Information 7.16.2 CR SECCO Pharmaceutical Co., Ltd Business Overview 7.16.3 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.16.4 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.16.5 CR SECCO Pharmaceutical Co., Ltd Recent Development 7.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd 7.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information 7.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview 7.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Products Offered 7.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Development 7.18 Renhetang Pharmaceutical Company Limited 7.18.1 Renhetang Pharmaceutical Company Limited Company Information 7.18.2 Renhetang Pharmaceutical Company Limited Business Overview 7.18.3 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.18.4 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Products Offered 7.18.5 Renhetang Pharmaceutical Company Limited Recent Development 7.19 Runenberg Pharmaceuticals Ltd 7.19.1 Runenberg Pharmaceuticals Ltd Company Information 7.19.2 Runenberg Pharmaceuticals Ltd Business Overview 7.19.3 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.19.4 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Products Offered 7.19.5 Runenberg Pharmaceuticals Ltd Recent Development 7.20 Nanjing Shenghe Pharmaceutical Co., Ltd 7.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Company Information 7.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview 7.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Development 7.21 Nanjing Sea Whale Pharmaceutical Co., Ltd 7.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information 7.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview 7.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2021-2026) 7.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Products Offered 7.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Development 8 Finasteride (Oral Route) Manufacturing Cost Analysis 8.1 Finasteride (Oral Route) Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Key Suppliers of Raw Materials 8.2 Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Finasteride (Oral Route) 8.4 Finasteride (Oral Route) Industrial Chain Analysis 9 Marketing Channels, Distributors and Customers 9.1 Marketing Channels 9.2 Finasteride (Oral Route) Distributors List 9.3 Finasteride (Oral Route) Customers 10 Finasteride (Oral Route) Market Dynamics 10.1 Finasteride (Oral Route) Industry Trends 10.2 Finasteride (Oral Route) Market Drivers 10.3 Finasteride (Oral Route) Market Challenges 10.4 Finasteride (Oral Route) Market Restraints 11 Research Findings and Conclusion 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.1.1 Research Programs/Design 12.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 12.1.2 Data Source 12.1.2.1 Secondary Sources 12.1.2.2 Primary Sources 12.2 Author Details 12.3 Disclaimer List of Tables/GraphsList of TablesTable 1. Global Finasteride (Oral Route) Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032) Table 2. Global Finasteride (Oral Route) Sales (US$ Million) Comparison by Application (2021, 2025 & 2032) Table 3. Global Market Finasteride (Oral Route) Market Size (US$ Million) by Region:2021 VS 2025 VS 2032 Table 4. Global Finasteride (Oral Route) Sales (K Pcs) by Region (2021-2026) Table 5. Global Finasteride (Oral Route) Sales Market Share by Region (2021-2026) Table 6. Global Finasteride (Oral Route) Revenue (US$ Million) Market Share by Region (2021-2026) Table 7. Global Finasteride (Oral Route) Revenue Share by Region (2021-2026) Table 8. Global Finasteride (Oral Route) Sales (K Pcs) Forecast by Region (2027-2032) Table 9. Global Finasteride (Oral Route) Sales Market Share Forecast by Region (2027-2032) Table 10. Global Finasteride (Oral Route) Revenue (US$ Million) Forecast by Region (2027-2032) Table 11. Global Finasteride (Oral Route) Revenue Share Forecast by Region (2027-2032) Table 12. Global Finasteride (Oral Route) Sales by Type (K Pcs) & (2021-2026) Table 13. Global Finasteride (Oral Route) Sales Share by Type (2021-2026) Table 14. Global Finasteride (Oral Route) Revenue by Type (US$ Million) & (2021-2026) Table 15. Global Finasteride (Oral Route) Average Price by Type (US$/Pcs) & (2021-2026) Table 16. Global Finasteride (Oral Route) Sales by Type (K Pcs) & (2027-2032) Table 17. Global Finasteride (Oral Route) Revenue by Type (US$ Million) & (2027-2032) Table 18. Global Finasteride (Oral Route) Average Price by Type (US$/Pcs) & (2027-2032) Table 19. Representative Players of Each Type Table 20. Global Finasteride (Oral Route) Sales by Application (K Pcs) & (2021-2026) Table 21. Global Finasteride (Oral Route) Sales Share by Application (2021-2026) Table 22. Global Finasteride (Oral Route) Revenue by Application (US$ Million) & (2021-2026) Table 23. Global Finasteride (Oral Route) Average Price by Application (US$/Pcs) & (2021-2026) Table 24. Global Finasteride (Oral Route) Sales by Application (K Pcs) & (2027-2032) Table 25. Global Finasteride (Oral Route) Revenue Market Share by Application (US$ Million) & (2027-2032) Table 26. Global Finasteride (Oral Route) Average Price by Application (US$/Pcs) & (2027-2032) Table 27. New Sources of Growth in Finasteride (Oral Route) Applications Table 28. Global Finasteride (Oral Route) Sales by Company (K Pcs) & (2021-2026) Table 29. Global Finasteride (Oral Route) Sales Share by Company (2021-2026) Table 30. Global Finasteride (Oral Route) Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Finasteride (Oral Route) Revenue Share by Company (2021-2026) Table 32. Global Finasteride (Oral Route) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Finasteride (Oral Route) as of 2025) Table 33. Global Market Finasteride (Oral Route) Average Price by Company (US$/Pcs) & (2021-2026) Table 34. Global Key Manufacturers of Finasteride (Oral Route), Manufacturing Sites & Headquarters Table 35. Global Key Manufacturers of Finasteride (Oral Route), Product Type & Application Table 36. Global Key Manufacturers of Finasteride (Oral Route), Date of Entry into This Industry Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans Table 38. North America Finasteride (Oral Route) Sales by Company (2021-2026) & (K Pcs) Table 39. North America Finasteride (Oral Route) Sales Market Share by Company (2021-2026) Table 40. North America Finasteride (Oral Route) Revenue by Company (2021-2026) & (US$ Million) Table 41. North America Finasteride (Oral Route) Revenue Market Share by Company (2021-2026) Table 42. North America Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs) Table 43. North America Finasteride (Oral Route) Sales Market Share by Type (2021-2026) Table 44. North America Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs) Table 45. North America Finasteride (Oral Route) Sales Market Share by Application (2021-2026) Table 46. Europe Finasteride (Oral Route) Sales by Company (2021-2026) & (K Pcs) Table 47. Europe Finasteride (Oral Route) Sales Market Share by Company (2021-2026) Table 48. Europe Finasteride (Oral Route) Revenue by Company (2021-2026) & (US$ Million) Table 49. Europe Finasteride (Oral Route) Revenue Market Share by Company (2021-2026) Table 50. Europe Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs) Table 51. Europe Finasteride (Oral Route) Sales Market Share by Type (2021-2026) Table 52. Europe Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs) Table 53. Europe Finasteride (Oral Route) Sales Market Share by Application (2021-2026) Table 54. China Finasteride (Oral Route) Sales by Company (2021-2026) & (K Pcs) Table 55. China Finasteride (Oral Route) Sales Market Share by Company (2021-2026) Table 56. China Finasteride (Oral Route) Revenue by Company (2021-2026) & (US$ Million) Table 57. China Finasteride (Oral Route) Revenue Market Share by Company (2021-2026) Table 58. China Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs) Table 59. China Finasteride (Oral Route) Sales Market Share by Type (2021-2026) Table 60. China Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs) Table 61. China Finasteride (Oral Route) Sales Market Share by Application (2021-2026) Table 62. Japan Finasteride (Oral Route) Sales by Company (2021-2026) & (K Pcs) Table 63. Japan Finasteride (Oral Route) Sales Market Share by Company (2021-2026) Table 64. Japan Finasteride (Oral Route) Revenue by Company (2021-2026) & (US$ Million) Table 65. Japan Finasteride (Oral Route) Revenue Market Share by Company (2021-2026) Table 66. Japan Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs) Table 67. Japan Finasteride (Oral Route) Sales Market Share by Type (2021-2026) Table 68. Japan Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs) Table 69. Japan Finasteride (Oral Route) Sales Market Share by Application (2021-2026) Table 70. Merck Company Information Table 71. Merck Description and Business Overview Table 72. Merck Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 73. Merck Finasteride (Oral Route) Product Table 74. Merck Recent Development Table 75. Sandoz Company Information Table 76. Sandoz Description and Business Overview Table 77. Sandoz Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 78. Sandoz Finasteride (Oral Route) Product Table 79. Sandoz Recent Development Table 80. Actavis Company Information Table 81. Actavis Description and Business Overview Table 82. Actavis Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 83. Actavis Finasteride (Oral Route) Product Table 84. Actavis Recent Development Table 85. Cipla Company Information Table 86. Cipla Description and Business Overview Table 87. Cipla Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 88. Cipla Finasteride (Oral Route) Product Table 89. Cipla Recent Development Table 90. RelonChem Company Information Table 91. RelonChem Description and Business Overview Table 92. RelonChem Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 93. RelonChem Finasteride (Oral Route) Product Table 94. RelonChem Recent Development Table 95. Dr. Reddy Company Information Table 96. Dr. Reddy Description and Business Overview Table 97. Dr. Reddy Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 98. Dr. Reddy Finasteride (Oral Route) Product Table 99. Dr. Reddy Recent Development Table 100. Accord Pharmaceuticals Company Information Table 101. Accord Pharmaceuticals Description and Business Overview Table 102. Accord Pharmaceuticals Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 103. Accord Pharmaceuticals Finasteride (Oral Route) Product Table 104. Accord Pharmaceuticals Recent Development Table 105. Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information Table 106. Hangzhou Kangenbei Pharmaceutical Co., Ltd Description and Business Overview Table 107. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 108. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 109. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Development Table 110. Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information Table 111. Hunan Zhengqing Pharmaceutical Group Co., Ltd Description and Business Overview Table 112. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 113. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product Table 114. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Development Table 115. Tianfang Pharmaceutical Co., Ltd Company Information Table 116. Tianfang Pharmaceutical Co., Ltd Description and Business Overview Table 117. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 118. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 119. Tianfang Pharmaceutical Co., Ltd Recent Development Table 120. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information Table 121. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Description and Business Overview Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Development Table 125. Zhejiang Xianju Pharmaceutical Co., Ltd Company Information Table 126. Zhejiang Xianju Pharmaceutical Co., Ltd Description and Business Overview Table 127. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 128. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 129. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Development Table 130. Shanghai Hyundai Pharmaceutical Co., Ltd Company Information Table 131. Shanghai Hyundai Pharmaceutical Co., Ltd Description and Business Overview Table 132. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 133. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 134. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Development Table 135. Hunan Baicao Pharmaceutical Co., Ltd Company Information Table 136. Hunan Baicao Pharmaceutical Co., Ltd Description and Business Overview Table 137. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 138. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 139. Hunan Baicao Pharmaceutical Co., Ltd Recent Development Table 140. Guangdong Yishu Pharmaceutical Co., Ltd Company Information Table 141. Guangdong Yishu Pharmaceutical Co., Ltd Description and Business Overview Table 142. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 143. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 144. Guangdong Yishu Pharmaceutical Co., Ltd Recent Development Table 145. CR SECCO Pharmaceutical Co., Ltd Company Information Table 146. CR SECCO Pharmaceutical Co., Ltd Description and Business Overview Table 147. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 148. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 149. CR SECCO Pharmaceutical Co., Ltd Recent Development Table 150. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information Table 151. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Description and Business Overview Table 152. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 153. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product Table 154. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Development Table 155. Renhetang Pharmaceutical Company Limited Company Information Table 156. Renhetang Pharmaceutical Company Limited Description and Business Overview Table 157. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 158. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product Table 159. Renhetang Pharmaceutical Company Limited Recent Development Table 160. Runenberg Pharmaceuticals Ltd Company Information Table 161. Runenberg Pharmaceuticals Ltd Description and Business Overview Table 162. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 163. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product Table 164. Runenberg Pharmaceuticals Ltd Recent Development Table 165. Nanjing Shenghe Pharmaceutical Co., Ltd Company Information Table 166. Nanjing Shenghe Pharmaceutical Co., Ltd Description and Business Overview Table 167. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 168. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 169. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Development Table 170. Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information Table 171. Nanjing Sea Whale Pharmaceutical Co., Ltd Description and Business Overview Table 172. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 173. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Table 174. Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Development Table 175. Production Base and Market Concentration Rate of Raw Material Table 176. Key Suppliers of Raw Materials Table 177. Finasteride (Oral Route) Distributors List Table 178. Finasteride (Oral Route) Customers List Table 179. Finasteride (Oral Route) Market Trends Table 180. Finasteride (Oral Route) Market Drivers Table 181. Finasteride (Oral Route) Market Challenges Table 182. Finasteride (Oral Route) Market Restraints Table 183. Research Programs/Design for This Report Table 184. Key Data Information from Secondary Sources Table 185. Key Data Information from Primary Sources List of Figures Figure 1. Finasteride (Oral Route) Product Picture Figure 2. Global Finasteride (Oral Route) Sales (US$ Million) by Type (2021, 2025 & 2032) Figure 3. Global Finasteride (Oral Route) Sales Market Share by Type in 2025 & 2032 Figure 4. 1mg Product Picture Figure 5. 5mg Product Picture Figure 6. Global Finasteride (Oral Route) Sales (US$ Million) by Application (2021, 2025 & 2032) Figure 7. Global Finasteride (Oral Route) Sales Market Share by Application in 2025 & 2032 Figure 8. Urology Examples Figure 9. Dermatology Examples Figure 10. Global Finasteride (Oral Route) Sales, (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Finasteride (Oral Route) Sales Growth Rate (2021-2032) & (US$ Million) Figure 12. Global Finasteride (Oral Route) Sales (K Pcs) Growth Rate (2021-2032) Figure 13. Global Finasteride (Oral Route) Price Trends Growth Rate (2021-2032) & (US$/Pcs) Figure 14. Finasteride (Oral Route) Report Years Considered Figure 15. Global Market Finasteride (Oral Route) Market Size (US$ Million) by Region:2021 VS 2025 VS 2032 Figure 16. Global Finasteride (Oral Route) Revenue Market Share by Region: 2021 VS 2025 Figure 17. North America Finasteride (Oral Route) Revenue (US$ Million) Growth Rate (2021-2032) Figure 18. North America Finasteride (Oral Route) Sales (K Pcs) Growth Rate (2021-2032) Figure 19. Europe Finasteride (Oral Route) Revenue (US$ Million) Growth Rate (2021-2032) Figure 20. Europe Finasteride (Oral Route) Sales (K Pcs) Growth Rate (2021-2032) Figure 21. China Finasteride (Oral Route) Revenue (US$ Million) Growth Rate (2021-2032) Figure 22. China Finasteride (Oral Route) Sales (K Pcs) Growth Rate (2021-2032) Figure 23. Japan Finasteride (Oral Route) Revenue (US$ Million) Growth Rate (2021-2032) Figure 24. Japan Finasteride (Oral Route) Sales (K Pcs) Growth Rate (2021-2032) Figure 25. Global Finasteride (Oral Route) Revenue Share by Type (2021-2026) Figure 26. Global Finasteride (Oral Route) Sales Share by Type (2027-2032) Figure 27. Global Finasteride (Oral Route) Revenue Share by Type (2027-2032) Figure 28. Global Finasteride (Oral Route) Revenue Share by Application (2021-2026) Figure 29. Global Finasteride (Oral Route) Revenue Market Share by Application in 2021 & 2025 Figure 30. Global Finasteride (Oral Route) Sales Share by Application (2027-2032) Figure 31. Global Finasteride (Oral Route) Revenue Share by Application (2027-2032) Figure 32. Global Finasteride (Oral Route) Sales Share by Company (2025) Figure 33. Global Finasteride (Oral Route) Revenue Share by Company (2025) Figure 34. Global 5 Largest Finasteride (Oral Route) Players Market Share by Revenue in Finasteride (Oral Route): 2021 & 2025 Figure 35. Finasteride (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. Manufacturing Cost Structure of Finasteride (Oral Route) Figure 37. Manufacturing Process Analysis of Finasteride (Oral Route) Figure 38. Finasteride (Oral Route) Industrial Chain Figure 39. Channels of Distribution (Direct Vs Distribution) Figure 40. Distributors Profiles Figure 41. Bottom-up and Top-down Approaches for This Report Figure 42. Data Triangulation Figure 43. Key Executives Interviewed
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の 医薬・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（competitive analysis）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
